Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

Official title: Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

Summary: To assess subject-centric real-world evidence of QoL outcomes in subjects enrolled in the global Phase 3 AU-011-301 clinical trial.

Conditions: Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma, Ocular Melanoma

Keywords: Uveal Melanoma, Eye Cancer, Ocular Melanoma, Choroidal Melanoma

Study type: OBSERVATIONAL

Enrollment: 15 (ESTIMATED)

Status: RECRUITING

Completion: 2028-08-15 (ESTIMATED)